Page last updated: 2024-09-05

esketamine and Dizzyness

esketamine has been researched along with Dizzyness in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Daly, EJ; Gogate, JP; Kern Sliwa, JK; Manera, LS; Preskorn, SH; Starr, HL; Williamson, DJ; Winokur, A1
Hu, W; Huang, X; Ren, W; Wang, J; Zhang, B; Zhao, X1
Chen, X; Du, C; Min, M; Xin, W1
Chen, G; Li, X; Wang, J; Wang, T; Xu, X; Xu, Z; Yang, S; Zhou, X1

Reviews

1 review(s) available for esketamine and Dizzyness

ArticleYear
Adverse Effects of Esketamine for the Treatment of Major Depression Disorder: Findings from Randomized Controlled Trials.
    The Psychiatric quarterly, 2022, Volume: 93, Issue:1

    Topics: Depression; Dizziness; Humans; Hypesthesia; Ketamine; Nausea; Paresthesia; Randomized Controlled Trials as Topic; Vertigo

2022

Trials

2 trial(s) available for esketamine and Dizzyness

ArticleYear
Sedative effect and safety of different doses of S-ketamine in combination with propofol during gastro-duodenoscopy in school-aged children: a prospective, randomized study.
    BMC anesthesiology, 2022, Nov-12, Volume: 22, Issue:1

    Topics: Anesthesia Recovery Period; Anesthetics, Intravenous; Child; Dizziness; Duodenoscopy; Humans; Hypnotics and Sedatives; Propofol; Prospective Studies

2022
Effect of subanesthetic dose of esketamine on postoperative rehabilitation in elderly patients undergoing hip arthroplasty.
    Journal of orthopaedic surgery and research, 2023, Apr-03, Volume: 18, Issue:1

    Topics: Aged; Analgesia, Patient-Controlled; Arthroplasty, Replacement, Hip; Dizziness; Femoral Neck Fractures; Humans; Interleukin-6; Ketamine; Pain, Postoperative; Quality of Life; Saline Solution; Sufentanil

2023

Other Studies

1 other study(ies) available for esketamine and Dizzyness

ArticleYear
Longitudinal Course of Adverse Events With Esketamine Nasal Spray: A Post Hoc Analysis of Pooled Data From Phase 3 Trials in Patients With Treatment-Resistant Depression.
    The Journal of clinical psychiatry, 2022, 09-19, Volume: 83, Issue:6

    Topics: Antidepressive Agents; Clinical Trials, Phase III as Topic; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dizziness; Humans; Ketamine; Nasal Sprays; Nausea; Vertigo

2022